It has been reported that tamoxifen-resistant MCF7-LR breast cancer cells exhibited elevated expression of GRP78 (Zhang et al, 2013; Cook & Clarke, 2015) and CD44 (Hiscox et al, 2012; Bellerby et al, 2016). This evidence concerns the gene CD44 and breast carcinoma.